392
Participants
Start Date
June 8, 2020
Primary Completion Date
August 20, 2020
Study Completion Date
September 5, 2020
Nitazoxanide
Nitazoxanide 500mg 8/8 hours for 5 days in the early clinical phase of COVID-19.
Placebo
Placebo 8/8 hours for 5 days in the early clinical phase of COVID-19.
Universidade Federal do Rio de Janeiro, Rio de Janeiro
Ministry of Science and Technology, Brazil
OTHER
National Research Council, Brazil
OTHER
ATCGen
UNKNOWN
Complexo Hospitalar Municipal de São Caetano do Sul
UNKNOWN
Hospital de Transplante Doutor Euryclides de Jesus Zerbini
OTHER
Secretaria Municipal de Saúde de Bauru
UNKNOWN
Santa Casa de Misericórdia de Sorocaba
UNKNOWN
Secretaria Municipal de Saúde de Guarulhos
UNKNOWN
Hospital e Maternidade Therezinha de Jesus
UNKNOWN
Secretaria de Estado de Saúde do Distrito Federal
UNKNOWN
Universidade Federal do Rio de Janeiro
OTHER